Blood Journals Portfolio/LinkedIn
Sep 8, 2025, 03:48
Blood Podcast Alert: Voxelotor Drops, Pediatric SCD, Thrombosis in VEXAS Syndrome and TKIs in ALL
Blood Journals Portfolio shared on LinkedIn:
”September is Sickle Cell Disease Awareness Month and together we are working to conquer SCD!
Effects of voxelotor on cerebral blood flow in pediatric sickle cell disease; thrombosis in Vexas syndrome; response to tyrosine kinase inhibitors in ABL-class acute lymphoblastic leukemia describes how voxelotor is raising hemoglobin.
Highlights are:
- Kids + sickle cell + voxelotor: Imagine your kid’s brain saying “thanks” while your hemoglobin goes up, up, up. Voxelotor drops cerebral blood flow and oxygen extraction to more normal levels—like a spa retreat for tiny brains in crisis.
- VEXAS syndrome, meet your match: Thrombosis stages its dramatic entrance—because immune dashboards love throwing plot twists.
- ABL-class ALL hitting back: Tyrosine kinase inhibitors show they still remember their moves—clocking responses like a perfect encore.
Listen to the full episode here.”
Stay tuned for the podcast series in hematology with Hemostasis Today.
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke
-
Dec 12, 2025, 07:00Umberto Pensato on Cancer and Stroke
-
Dec 12, 2025, 06:48Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
-
Dec 12, 2025, 06:30Anirban Sen Gupta on Synthetic Platelets
-
Dec 12, 2025, 05:59Gaetan Duport: A New Legislation for Medicines in Europe